Serum vitamin D, hemoglobin A1c and vitamin B12 levels in patients with gingivitis and periodontitis stages.

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc and Cyanocobalamin (Vitamin B12), published as a clinical trial.

Aim: To compare the serum vitamin D, hemoglobin A1c (HbA1c) and vitamin B12 levels in patients with gingivitis and four different periodontitis stages diagnosed according to the 2017 Periodontal Disease Classification.

Why It Was Studied

Patients were divided into groups based on disease stage, and the HbA1c, vitamin D and B12 levels of the patients were compared and analyzed.

Who Took Part

According to the abstract, 606 patients were involved.

PubMed indexes the participants as adults and middle-aged adults, both men and women.

Materials & methods: A total of 606 patients were included in the study who were diagnosed with gingivitis and stage I-IV periodontitis.

What Was Measured

Patients were divided into groups based on disease stage, and the HbA1c, vitamin D and B12 levels of the patients were compared and analyzed.

The subject headings attached to it are Gingivitis, Glycated Hemoglobin, Periodontitis, Vitamin B 12 and Vitamin D.

The authors tagged it with the keywords HbA1c, risk factors and vitamin B12.

What This Means in Plain Language

This is a clinical trial of Vitamin D, K2, Magnesium and Zinc and Cyanocobalamin (Vitamin B12) in 606 patients.

With several hundred people or more, it is a fairly large study for this kind of research.

The publication is from 2024 (Biomarkers in medicine), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page and the Cyanocobalamin (Vitamin B12) compound page, all human trials.